Latest Reserves News

Cambium Bio has secured FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development costs and timelines. Despite a AUD 4.1 million loss for FY2026, the company strengthened its funding position and manufacturing partnerships ahead of patient dosing targeted for late 2026.

First Graphene lifted revenue by 15% to $537,594 for FY26 while narrowing its net loss slightly to $5.4 million. Key acquisitions and a landmark China cement distribution MOU set the stage for commercial expansion.

SIV Capital posted a 244% increase in net loss for FY26 to $388,049 on a 33% revenue drop, with its legacy rental business winding down and ASX suspension ongoing. The company is pursuing a new transaction to regain listing approval.

Elixir Energy has marked FY26 with major progress in Queensland’s Taroom Trough, expanding contingent gas resources by 32% and securing a strategic $16.6 million capital raise led by Omega Oil and Gas. The company’s operational advances and government backing position it as a key player in Australia’s energy security landscape.

BKI Investment Company has expanded its risk disclosure, outlining significant market, income, operational, and regulatory risks that could influence its financial outcomes and shareholder dividends.

Locality Planning Energy (ASX:LPE) reversed losses to post a $2.31 million statutory profit in FY2026, driven by strategic acquisitions, improved earnings, and a strengthened balance sheet.

Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.

Foresta Group Holdings reports a doubling of its net loss to $6.8 million for FY2026 amid steady progress on its Kawerau biomass facility, highlighted by a long-term lease and key technical studies.

Berkeley Energia reported a $8.7 million net loss for FY2026 while pushing forward with its Salamanca uranium project and maiden critical minerals resource at Conchas. The company continues a $1.25 billion ICSID arbitration claim against Spain over permitting delays.

ADX Energy’s HOCH-1 shallow gas well in Upper Austria has produced a combined gas flow of 3.15 million cubic feet per day from multiple zones, reinforcing the well’s commercial potential amid Europe’s gas supply crunch.

Mirrabooka Investments posted a 63.6% profit increase to $13 million for FY26 but saw its portfolio return lag the benchmark. The company declared a 14 cents fully franked dividend and welcomed Alison Gibson as new CEO following Mark Freeman's retirement.

WAM Alternative Assets nearly doubled its pre-tax profit in FY2026, driven by a 9.1% portfolio gain and a decisive shareholder vote backing its strategy. The company declared a 6.0 cents per share dividend, partially franked at 60%, reflecting portfolio maturation and diversification.